Winchester, MA, United States of America

Mary Ellen Digan


 

Average Co-Inventor Count = 5.2

ph-index = 2

Forward Citations = 89(Granted Patents)


Location History:

  • Morristown, NJ (US) (2002)
  • Winchester, MA (US) (2010 - 2015)

Company Filing History:


Years Active: 2002-2015

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Mary Ellen Digan: Innovator in Immunotoxin Fusion Proteins

Introduction

Mary Ellen Digan is a notable inventor based in Winchester, MA (US). She has made significant contributions to the field of immunotoxin fusion proteins, holding a total of 4 patents. Her work focuses on developing novel recombinant immunotoxins that have the potential to advance medical treatments.

Latest Patents

One of her latest patents is titled "Immunotoxin fusion proteins and means for expression thereof." This invention provides novel recombinant DT-based immunotoxins, specifically targeting anti-T cell immunotoxin fusion proteins. The patent details immunotoxins that can be expressed in various cell types, including bacterial, yeast, or mammalian cells. The invention also outlines methods for the expression of the immunotoxin fusion protein, ensuring compliance with technical disclosure requirements.

Career Highlights

Mary Ellen Digan has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and Novartis AG. Her experience in these institutions has contributed to her expertise in the field of immunology and biotechnology.

Collaborations

Throughout her career, Mary Ellen has collaborated with notable colleagues such as David M Neville and Jerry Todd Thompson. These collaborations have likely enriched her research and innovation efforts.

Conclusion

Mary Ellen Digan's contributions to the field of immunotoxin fusion proteins demonstrate her commitment to advancing medical science. Her innovative patents and collaborations highlight her role as a significant figure in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…